Pharmacotherapy of Sexual Addiction - Archive ouverte HAL Access content directly
Journal Articles Current Psychiatry Reports Year : 2020

Pharmacotherapy of Sexual Addiction

(1, 2) , (1, 2) , (1, 2) , (3)
1
2
3

Abstract

Purpose of review: We reviewed recent data on sexual addiction and its treatment. We examined the different definitions of this disorder, related to the pathophysiological mechanisms. We addressed the pharmacological treatment of sexual addiction. Recent findings: Hypersexual behavior can be considered an addictive disorder. Sexual addiction is accompanied by significant psychiatric and addictive comorbidities and is responsible for life impairment. A comprehensive and efficient treatment must be proposed. Selective serotonin reuptake inhibitors seem the first-line pharmacological treatment for sexual addiction. Naltrexone could be another therapeutic option. Psychotherapy and preferentially cognitive-behavioral therapy should be used in association with pharmacotherapy and treatments of comorbidities.
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

inserm-02881439 , version 1 (25-06-2020)

Identifiers

Cite

Leo Malandain, Jean-Victor Blanc, Florian Ferreri, Florence Thibaut. Pharmacotherapy of Sexual Addiction. Current Psychiatry Reports, 2020, 22 (6), pp.30. ⟨10.1007/s11920-020-01153-4⟩. ⟨inserm-02881439⟩
67 View
2 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More